Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price target lowered by BMO Capital Markets from $467.00 to $404.00 in a ...
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage ...
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...
BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results